[Qidong Chronic Hepatitis B Cohort: participants enrollment and comparison of baseline characteristics by gender stratification]
- PMID: 29141351
- DOI: 10.3760/cma.j.issn.0254-6450.2017.11.026
[Qidong Chronic Hepatitis B Cohort: participants enrollment and comparison of baseline characteristics by gender stratification]
Abstract
Objective: To establish a study cohort of chronic hepatitis B (CHB) in Qidong and evaluate its baseline characteristics. Methods: CHB outpatients of the Third People's Hospital of Qidong were invited to participate in baseline survey from January 1, 2016, including questionnaire survey, liver function detection, serum detection of HBV infection and upper abdomen ultrasound detection. Anticipated sample size was at least one thousand. Baseline data were inputted by EpiData 3.1 software and then cleaned and analyzed by SAS 9.3 software. Results: As of 18 July, 2016, a total of 1 006 participants had been enrolled into the current study, including 615 males with an average age of (44.26±9.97) years and 391 females with an average age of (46.66±11.17) years. The difference in family history of liver disease was not significant between males and females (P>0.05), while the differences in other key information, such as age, education level, tobacco consumption, alcohol drinking, tea consumption, and antiviral intervention, were significant between males and females (P<0.05). Among the key clinical parameters, such as ALT, HBeAg, HBsAg, HBV DNA, albumin, and width of splenic vein and portal vein, only the abnormal rates of ALT and total bilirubin levels were higher in males than in females, the difference was significant (P<0.05). Conclusion: Outpatient department-based CHB cohort was established successfully in Qidong, and sub-cohort could be divided according to the differences on baseline characteristics.
目的: 在启东现场建立目标人群为慢性乙型肝炎(乙肝)患者的前瞻队列并分析其基线特征。 方法: 自2016年1月1日,对启东市第三人民医院门诊慢性乙肝患者开展基线调查,内容包括问卷调查、肝功能及HBV感染相关血清学指标检测、上腹部B超。计划纳入慢性乙肝患者不少于1 000例,基线调查资料采用EpiData软件录入,导入SAS 9.3软件后对研究对象的主要基线特征进行统计分析。 结果: 截至2016年7月18日,共1 006例研究对象签署知情同意并参加基线调查,其中男性615例,年龄为(44.26±9.97)岁,女性391例,年龄为(46.66±11.17)岁。肝病家族史性别间的差异无统计学意义(P>0.05),年龄、文化程度、吸烟、饮酒、饮茶、抗病毒治疗构成比的组间差异均有统计学意义(P<0.05)。临床指标方面,男性中ALT及总胆红素异常率高于女性,差异有统计学意义(P<0.05),HBeAg状态、HBsAg定量、HBV DNA载量、白蛋白、门静脉和脾静脉宽度异常构成比的组间差异均无统计学意义(P>0.05)。 结论: 在启东现场成功开展慢性乙肝门诊患者前瞻队列的基线调查,根据亚组间的基线特征差异,后续可进行相应的亚队列研究。.
Keywords: Chronic hepatitis B; Cohort study; Hepatitis B virus.
Similar articles
-
Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):635-643. doi: 10.1016/j.clinre.2017.03.004. Epub 2017 Apr 21. Clin Res Hepatol Gastroenterol. 2017. PMID: 28438570
-
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.Turk J Gastroenterol. 2015 Jan;26(1):36-41. doi: 10.5152/tjg.2015.4636. Turk J Gastroenterol. 2015. PMID: 25698269
-
Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.J Hepatol. 2011 Jul;55(1):61-8. doi: 10.1016/j.jhep.2010.10.027. Epub 2010 Dec 5. J Hepatol. 2011. PMID: 21145875
-
Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?J Clin Microbiol. 2017 Oct;55(10):2972-2982. doi: 10.1128/JCM.00760-17. Epub 2017 Jul 26. J Clin Microbiol. 2017. PMID: 28747369 Free PMC article.
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
Cited by
-
Incidence and Influencing Factors of New Hepatitis B Infections and Spontaneous Clearance: A Large-Scale, Community-Based Study in China.Front Med (Lausanne). 2021 Nov 18;8:717667. doi: 10.3389/fmed.2021.717667. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34869415 Free PMC article.
-
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2021 Feb;6(2):106-119. doi: 10.1016/S2468-1253(20)30307-1. Epub 2020 Nov 14. Lancet Gastroenterol Hepatol. 2021. PMID: 33197397 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
